Bank of New York Mellon’s NeueHealth NEUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,942
Closed -$140K 4468
2023
Q1
$140K Sell
7,942
-556
-7% -$28.7K ﹤0.01% 4013
2022
Q4
$442K Hold
8,498
﹤0.01% 3606
2022
Q3
$714K Buy
8,498
+2,024
+31% +$269K ﹤0.01% 3376
2022
Q2
$942K Sell
6,474
-1,768
-21% -$257K ﹤0.01% 3246
2022
Q1
$1.27M Buy
8,242
+6,612
+406% +$1.47M ﹤0.01% 3162
2021
Q4
$448K Buy
1,630
+204
+14% +$94.2K ﹤0.01% 3875
2021
Q3
$930K Buy
+1,426
New +$1.25M ﹤0.01% 3433

Other funds holding NEUE

Bank of New York Mellon's NEUE Position: Q2 2023 in Review

Bank of New York Mellon sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 7,942 shares — an estimated $140K sold.

Bank of New York Mellon first reported a position in NEUE in Q3 2021 and held it in 7 quarters. The position peaked at $1.27M in Q1 2022. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • Bank of New York Mellon reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 7,942 NeueHealth shares in Q2 2023, an estimated $140K.
  • Bank of New York Mellon first reported a position in NeueHealth in Q3 2021 and held it in 7 quarters.
  • Bank of New York Mellon's NeueHealth position peaked at $1.27M in Q1 2022.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.